228 related articles for article (PubMed ID: 35950745)
21. A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis.
Cefle A; Kamali S; Sayarlioglu M; Inanc M; Ocal L; Aral O; Konice M; Gul A
Rheumatol Int; 2005 Aug; 25(6):442-6. PubMed ID: 15290087
[TBL] [Abstract][Full Text] [Related]
22. Can colchicine response be predicted in familial Mediterranean fever patients?
Özçakar ZB; Elhan AH; Yalçınkaya F
Rheumatology (Oxford); 2014 Oct; 53(10):1767-72. PubMed ID: 24764265
[TBL] [Abstract][Full Text] [Related]
23. Familial Mediterranean fever patients may have unmet needs for treatment of erysipelas-like erythema.
Tezcan ME
Clin Exp Rheumatol; 2017; 35 Suppl 104(2):9. PubMed ID: 27782864
[No Abstract] [Full Text] [Related]
24. NOD2/CARD15 gene mutations in patients with familial Mediterranean fever.
Berkun Y; Karban A; Padeh S; Pras E; Shinar Y; Lidar M; Livneh A; Bujanover Y
Semin Arthritis Rheum; 2012 Aug; 42(1):84-8. PubMed ID: 22244368
[TBL] [Abstract][Full Text] [Related]
25. Skin and muscle involvement as presenting symptoms in four children with familial Mediterranean fever.
Kavukcu S; Türkmen M; Soylu A; Kasap B; Tatli Güneş B
Clin Rheumatol; 2009 Jul; 28(7):857-60. PubMed ID: 19240979
[TBL] [Abstract][Full Text] [Related]
26. [Unusual cutaneous lesions of familial Mediterranean fever].
Bafounta ML; Doumat-Batch F; Vasseur E; Staroz F; Clerici T; Saiag P
Ann Dermatol Venereol; 2004 Feb; 131(2):183-6. PubMed ID: 15026746
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous necrotizing vasculitis as a manifestation of familial Mediterranean fever.
Komatsu S; Honma M; Igawa S; Tsuji H; Ishida-Yamamoto A; Migita K; Ida H; Iizuka H
J Dermatol; 2014 Sep; 41(9):827-9. PubMed ID: 25109905
[TBL] [Abstract][Full Text] [Related]
28. An overview of familial Mediterranean fever with emphasis on pyrin and colchicine.
Dbouk HA; Uthman IW
J Med Liban; 2008; 56(1):35-41. PubMed ID: 19534089
[TBL] [Abstract][Full Text] [Related]
29. Age of onset as an influencing factor for disease severity in children with familial Mediterranean fever.
Tanatar A; Karadağ ŞG; Çakan M; Sönmez HE; Ayaz NA
Mod Rheumatol; 2021 Jan; 31(1):219-222. PubMed ID: 31999206
[TBL] [Abstract][Full Text] [Related]
30. Musculoskeletal manifestations occur predominantly in patients with later-onset familial Mediterranean fever: Data from a multicenter, prospective national cohort study in Japan.
Endo Y; Koga T; Ishida M; Fujita Y; Tsuji S; Takatani A; Shimizu T; Sumiyoshi R; Igawa T; Umeda M; Fukui S; Nishino A; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Agematsu K; Yachie A; Masumoto J; Migita K; Kawakami A
Arthritis Res Ther; 2018 Nov; 20(1):257. PubMed ID: 30458853
[TBL] [Abstract][Full Text] [Related]
31. Fas and Fas ligand gene polymorphisms in Turkish patients with Familial Mediterranean Fever.
Ozel EG; Duran GG; Celik MM; Duran N; Gunesacar R
Gene; 2017 Aug; 623():29-32. PubMed ID: 28442396
[TBL] [Abstract][Full Text] [Related]
32. Febrile seizures in children with familial Mediterranean fever: Coincidence or association?
Çomak E; Tüfekçi Ö; Kılıçbay F; Isıyel E; Sever AH; Aslanger A; Ekici B
Eur J Paediatr Neurol; 2015 Sep; 19(5):572-6. PubMed ID: 26028444
[TBL] [Abstract][Full Text] [Related]
33. Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever.
Shinar Y; Livneh A; Langevitz P; Zaks N; Aksentijevich I; Koziol DE; Kastner DL; Pras M; Pras E
J Rheumatol; 2000 Jul; 27(7):1703-7. PubMed ID: 10914855
[TBL] [Abstract][Full Text] [Related]
34. Erysipelas-like erythema with familial Mediterranean fever.
Aydin F; Ozcelik C; Akpolat I; Turanli AY; Akpolat T
J Dermatol; 2011 May; 38(5):513-5. PubMed ID: 21352275
[No Abstract] [Full Text] [Related]
35. The cutaneous manifestations in children with familial Mediterranean fever (recurrent hereditary polyserositis). A six-year study.
Majeed HA; Quabazard Z; Hijazi Z; Farwana S; Harshani F
Q J Med; 1990 Jun; 75(278):607-16. PubMed ID: 2217666
[TBL] [Abstract][Full Text] [Related]
36. FMF is not always "fever": from clinical presentation to "treat to target".
Maggio MC; Corsello G
Ital J Pediatr; 2020 Jan; 46(1):7. PubMed ID: 31941537
[TBL] [Abstract][Full Text] [Related]
37. Adult-onset familial mediterranean Fever in northwestern iran; clinical feature and treatment outcome.
Nobakht H; Zamani F; Ajdarkosh H; Mohamadzadeh Z; Fereshtehnejad S; Nassaji M
Middle East J Dig Dis; 2011 Mar; 3(1):50-5. PubMed ID: 25197532
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous manifestations of familial Mediterranean fever.
Azizi E; Fisher BK
Arch Dermatol; 1976 Mar; 112(3):364-6. PubMed ID: 1259449
[TBL] [Abstract][Full Text] [Related]
39. Familial Mediterranean Fever in Crete: a genetic and structural biological approach in a population of 'intermediate risk'.
Fragouli E; Eliopoulos E; Petraki E; Sidiropoulos P; Aksentijevich I; Galanakis E; Kritikos H; Repa A; Fragiadakis G; Boumpas D; Goulielmos GN
Clin Genet; 2008 Feb; 73(2):152-9. PubMed ID: 18177465
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of subclinical inflammation in familial Mediterranean fever patients: relations with mutation types and attack status: a retrospective study.
Kelesoglu FM; Aygun E; Okumus NK; Ersoy A; Karapınar E; Saglam N; Aydın NG; Senay BB; Gonultas S; Sarisik E; Can MZ; Atay S; Basbug D; Tiryaki FK; Ozer S; Durmus RB; Orem F; Atay T; Acar A; Yilmaz Y; Kaya S; Ciftkaya A; Sarac Z; Makar CC; Saracoglu B; Dogdu G; Omeroglu RE
Clin Rheumatol; 2016 Nov; 35(11):2757-2763. PubMed ID: 27106545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
